Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michiel Coppens

Showing results (101-110 of 143) with videos related to

Pageof 15
Sort By:
Research and Practice in Thrombosis and Haemostasis|December 1, 2021
Generic PROMIS item banks in adults with hemophilia for patient-reported outcome assessment: Feasibility, measurement properties, and relevanceIsolde A R Kuijlaars, Lorynn Teela, Lize F D van Vulpen, et al.
Thrombosis Research|September 20, 2020
ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 monthsGiancarlo Agnelli, Ulrich Hoffmann, Philippe Hainaut, et al.
Research and Practice in Thrombosis and Haemostasis|March 3, 2023
In patients with hemophilia, a decreased thrombin generation profile is associated with a severe bleeding phenotypeMarieke J A Verhagen, Waander L van Heerde, Johanna G van der Bom, et al.
Research and Practice in Thrombosis and Haemostasis|September 12, 2022
Desmopressin for bleeding in non-severe hemophilia A: Suboptimal use in a real-world settingAnne-Fleur Zwagemaker, Fabienne R Kloosterman, Michiel Coppens, et al.
Atherosclerosis|January 7, 2022
Lipoprotein(a), venous thromboembolism and COVID-19: A pilot studyNick S Nurmohamed, Didier Collard, Laurens F Reeskamp, et al.
Journal of Thrombosis and Haemostasis : JTH|August 28, 2025
Diagnostic accuracy of CT venography compared to ultrasonography for detection of peripherally inserted central venous catheter-related thrombosis in patients with cancer: the DETECT studyNoori A M Guman, Bart M van Dooremaal, Ludo F Beenen, et al.
American Journal of Hematology|October 30, 2019
The limitation of genetic testing in diagnosing patients suspected for congenital platelet defectsMaaike W Blaauwgeers, Ivar van Asten, Marieke J H A Kruip, et al.
British Journal of Clinical Pharmacology|August 11, 2023
A new population pharmacokinetic model for recombinant factor IX-Fc fusion concentrate including young children with haemophilia BSjoerd F Koopman, Tine M H J Goedhart, Laura H Bukkems, et al.
Thrombosis Journal|June 2, 2018
Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) studyAlexander T Cohen, Cihan Ay, Philippe Hainaut, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|March 14, 2022
Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study)Tine M H J Goedhart, Laura H Bukkems, Michiel Coppens, et al.
Pageof 15

Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
Research and Practice in Thrombosis and Haemostasis|December 1, 2021
Generic PROMIS item banks in adults with hemophilia for patient-reported outcome assessment: Feasibility, measurement properties, and relevanceIsolde A R Kuijlaars, Lorynn Teela, Lize F D van Vulpen, et al.
Thrombosis Research|September 20, 2020
ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 monthsGiancarlo Agnelli, Ulrich Hoffmann, Philippe Hainaut, et al.
Research and Practice in Thrombosis and Haemostasis|March 3, 2023
In patients with hemophilia, a decreased thrombin generation profile is associated with a severe bleeding phenotypeMarieke J A Verhagen, Waander L van Heerde, Johanna G van der Bom, et al.
Research and Practice in Thrombosis and Haemostasis|September 12, 2022
Desmopressin for bleeding in non-severe hemophilia A: Suboptimal use in a real-world settingAnne-Fleur Zwagemaker, Fabienne R Kloosterman, Michiel Coppens, et al.
Atherosclerosis|January 7, 2022
Lipoprotein(a), venous thromboembolism and COVID-19: A pilot studyNick S Nurmohamed, Didier Collard, Laurens F Reeskamp, et al.
Journal of Thrombosis and Haemostasis : JTH|August 28, 2025
Diagnostic accuracy of CT venography compared to ultrasonography for detection of peripherally inserted central venous catheter-related thrombosis in patients with cancer: the DETECT studyNoori A M Guman, Bart M van Dooremaal, Ludo F Beenen, et al.
American Journal of Hematology|October 30, 2019
The limitation of genetic testing in diagnosing patients suspected for congenital platelet defectsMaaike W Blaauwgeers, Ivar van Asten, Marieke J H A Kruip, et al.
British Journal of Clinical Pharmacology|August 11, 2023
A new population pharmacokinetic model for recombinant factor IX-Fc fusion concentrate including young children with haemophilia BSjoerd F Koopman, Tine M H J Goedhart, Laura H Bukkems, et al.
Thrombosis Journal|June 2, 2018
Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) studyAlexander T Cohen, Cihan Ay, Philippe Hainaut, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|March 14, 2022
Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study)Tine M H J Goedhart, Laura H Bukkems, Michiel Coppens, et al.
Pageof 15